• Markets
  • icon
  • Companies
PYC · ASX

PYC Therapeutics Limited (ASX:PYC)

AU$0.096

 -0.004 (-4.0%)
ASX:Live
12/04/2024 04:10:59 PM
Hammer Bearish HALO Price Momentum HALO Ords HALO Consensus Value GROWTH AUS +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

PYC Overview

PYC Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About PYC

Telephone

Address

Description

PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.

PYC Price Chart

Key Stats

Market Cap

AU$466.61M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.11

Trade Value (12mth)

AU$27,526.00

1 week

11.63%

1 month

14.29%

YTD

-2.86%

1 year

48.31%

All time high

0.649211

Key Fundamentals

EPS 3 yr Growth

184.000%

EBITDA Margin

N/A

Operating Cashflow

-$24m

Free Cash Flow Return

-71.90%

ROIC

-67.10%

Interest Coverage

-1,402.90

Quick Ratio

3.80

Other Data

Shares on Issue (Fully Dilluted)

3777m

HALO Sector

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.05

PYC Announcements

Latest Announcements

Date Announcements

12 April 24

Application for quotation of securities - PYC

×

Application for quotation of securities - PYC

11 April 24

Change in substantial holding

×

Change in substantial holding

10 April 24

$74.6 Million Extension of Cash Runway

×

$74.6 Million Extension of Cash Runway

03 April 24

Notification of cessation of securities - PYC

×

Notification of cessation of securities - PYC

28 March 24

Change in substantial holding

×

Change in substantial holding

28 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 March 24

Notification of cessation of securities - PYC

×

Notification of cessation of securities - PYC

25 March 24

Application for quotation of securities - PYC

×

Application for quotation of securities - PYC

20 March 24

Retail Entitlement Offer Booklet

×

Retail Entitlement Offer Booklet

20 March 24

Despatch of Retail Offer Document

×

Despatch of Retail Offer Document

20 March 24

Despatch of Notice to Ineligible Retail Shareholders

×

Despatch of Notice to Ineligible Retail Shareholders

18 March 24

Completion of Institutional Entitlement Offer

×

Completion of Institutional Entitlement Offer

15 March 24

Update - Proposed issue of securities - PYC

×

Update - Proposed issue of securities - PYC

15 March 24

Amended Appendix 3B

×

Amended Appendix 3B

14 March 24

Trading Halt

×

Trading Halt

14 March 24

PYC Equity Raising to Raise up to $74.6 Million

×

PYC Equity Raising to Raise up to $74.6 Million

14 March 24

PYC Equity Raising Presentation

×

PYC Equity Raising Presentation

14 March 24

Proposed issue of securities - PYC

×

Proposed issue of securities - PYC

14 March 24

Cleansing Notice Under Section 708AA

×

Cleansing Notice Under Section 708AA

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

28 February 24

RP11 Clinical Trial - Dosing Completed in Cohort 3

×

RP11 Clinical Trial - Dosing Completed in Cohort 3

26 February 24

Change of Registered Office

×

Change of Registered Office

16 February 24

Receipt of $4.5m Collaboration Fee

×

Receipt of $4.5m Collaboration Fee

06 February 24

Euroz Hartleys Healthcare Conference Presentation

×

Euroz Hartleys Healthcare Conference Presentation

02 February 24

Q1 2024 Investor Webinar Presentation

×

Q1 2024 Investor Webinar Presentation

PYC Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -132.0 24.1 -61.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -130.0 10.7 -62.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -2.6 -10.7 -13.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.01 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 90.4 -27.9 -37.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 3,092 3,181 3,211 Lock Lock Lock
Basic m Lock Lock Lock Lock 3,092 3,181 3,211 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 21 29 38 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.8 -34.9 -5.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -21 -29 -38 Lock Lock Lock
     Growth % Lock Lock Lock Lock -131.7 -38.5 -30.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -22 -30 -39 Lock Lock Lock
     Growth % Lock Lock Lock Lock -125.0 -38.4 -29.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -22 -30 -39 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -16 -16 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -18 -14 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -160.4 22.0 -64.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -12 -22 -24 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -16 33 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 39 0 11 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -12 -22 -25 Lock Lock Lock
     Growth % Lock Lock Lock Lock -111.5 -79.0 -12.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 52 29 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 58 45 37 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -51 -28 -15 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 5 9 Lock Lock Lock
Equity $m Lock Lock Lock Lock 53 39 28 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 54 40 28 Lock Lock Lock
     Growth % Lock Lock Lock Lock 84.2 -25.3 -30.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -30.7 -30.6 -61.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.5 -35.2 -82.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -51.0 -63.1 -112.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -43.2 -29.6 -67.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -28.7 -46.5 -71.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -546.4 -901.0 -1,402.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.4 1.0 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -95.7 -71.6 -55.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 15.7 8.9 3.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 15.7 8.9 3.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 99.5 74.2 48.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -357.6 -496.4 -290.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -30.7 -30.6 -61.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.5 -35.2 -82.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -33.5 -35.2 -82.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 716.5 1,069.8 1,550.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -716.5 -1,069.8 -1,550.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.05%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PYC Shortsell

Frequently Asked Questions

The current share price of PYC Therapeutics Limited (PYC:ASX) is AU$0.096.
The 52-week high share price for PYC Therapeutics Limited (PYC:ASX) is AU$0.11.
The 52-week low share price for PYC Therapeutics Limited (PYC:ASX)? is AU$0.05.
PYC Therapeutics Limited (PYC:ASX) does not pay a dividend.
PYC Therapeutics Limited (PYC:ASX) does not pay a dividend.
PYC Therapeutics Limited (PYC:ASX) has a franking level of 0%.
PYC Therapeutics Limited (PYC:ASX) is classified in the Healthcare.
The current P/E ratio for PYC Therapeutics Limited (PYC:ASX) is .